Technology | June 20, 2011

Boston Scientific Launches Mustang PTA Balloon Catheter Worldwide

June 20, 2011 — Boston Scientific Corporation today announced the global launch of its Mustang PTA balloon catheter, a highly deliverable 0.035-inch percutaneous transluminal angioplasty (PTA) catheter designed for a wide range of peripheral angioplasty procedures. The company plans to launch the product immediately in the United States, Europe and other international markets.

Boston Scientific developed the Mustang to meet physician needs for a low-profile, high-pressure balloon catheter in a wide range of sizes.  It is the first to use Boston Scientific's NyBax balloon material, a proprietary co-extrusion of nylon and Pebax polymers engineered to provide high-pressure, non-compliant dilatation in a low-profile balloon.  It offers a rated burst pressure of up to 24 atmospheres and is the only 7 x 200 mm balloon compatible with a 5 French introducer sheath. Boston Scientific offers the balloon in 203 sizes.  

An estimated 8 to 10 million patients in the United States alone suffer from peripheral artery disease (PAD), which is characterized by blockages in vessels of the peripheral vasculature and is associated with high rates of morbidity. PTA balloon catheters are used in peripheral angioplasty and stenting procedures to open blocked arteries.  

For more information: www.bostonscientific.com 


Related Content

News | Balloon Catheter

June 13, 2024 — The U.S. Food and Drug Administration (FDA) announced that Teleflex, and their subsidiary Arrow ...

Home June 13, 2024
Home
News | Balloon Catheter

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
Home
News | Balloon Catheter

January 18, 2024 — Summa Therapeutics, LLC announced that the first-in-man injectable angioplasty procedures for ...

Home January 18, 2024
Home
News | Balloon Catheter
Cardiovascular Systems, Inc., a medical device company developing and commercializing innovative interventional ...
Home February 25, 2022
Home
News | Balloon Catheter

February 15, 2022 – CERENOVUS, an emerging leader in neurovascular care and part of Johnson & Johnson Medical Devices ...

Home February 15, 2022
Home
News | Balloon Catheter

May 20, 2021 — Boston Scientific Corporation announced it has initiated the AGENT IDE trial for the Agent Drug-Coated ...

Home May 20, 2021
Home
Feature | Balloon Catheter | By Dave Fornell, Editor

The first devices developed for interventional cardiology were percutaneous transluminal coronary angioplasty (PTCA) ...

Home March 16, 2021
Home
Feature | Balloon Catheter

February 17, 2021 — The U.S. Food and Drug Administration (FDA) has cleared Shockwave Medical's Intravascular ...

Home February 17, 2021
Home
News | Balloon Catheter

June 4, 2020 — Transit Scientific announced the U.S. Food and Drug Administration (FDA) cleared the XO Score ...

Home June 04, 2020
Home
News | Balloon Catheter

February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters — ...

Home February 24, 2020
Home
Subscribe Now